{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:28:06Z","timestamp":1724891286543},"reference-count":6,"publisher":"Scientific Scholar","content-domain":{"domain":["nmji.in"],"crossmark-restriction":true},"short-container-title":["NMJI"],"abstract":"<jats:p>Herpes zoster is a viral infection caused due to the reactivation of varicella-zoster virus that is localized to a single dermatome unilaterally. The factors responsible for its reactivation are increasing age, immunosuppressive drugs, malignancies, chronic liver and renal diseases. Herpes zoster was found to be one of the cutaneous manifestations of coronavirus disease 2019 (Covid-19). Various skin manifestations post-vaccination are being reported, which include injection site urticarial, maculopapular rash and positive dermographism. We report a patient of herpes zoster triggered by the viral vector (ChAdOx1 nCoV-19) coronavirus vaccine (recombinant).<\/jats:p>","DOI":"10.25259\/nmji_456_21","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T07:06:24Z","timestamp":1724828784000},"page":"89-90","update-policy":"http:\/\/dx.doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Herpes zoster triggered by ChAdOx1 nCoV-19 coronavirus vaccine (recombinant)"],"prefix":"10.25259","volume":"37","author":[{"given":"NEETHU MARY","family":"GEORGE","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"key":"10.25259\/NMJI_456_21\/ref-1","doi-asserted-by":"publisher","first-page":"9360476","DOI":"10.1155\/2020\/9360476","article-title":"A review of the dermatological manifestations of coronavirus disease 2019 (COVID-19)","volume":"2020","author":"Marraha","year":"2020","journal-title":"Dermatol Res Pract"},{"key":"10.25259\/NMJI_456_21\/ref-2","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S0140-6736(99)00623-6","article-title":"Reactivation of herpesvirus infections after vaccinations?","volume":"353","author":"Walter","year":"1999","journal-title":"Lancet"},{"key":"10.25259\/NMJI_456_21\/ref-3","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jdcr.2020.05.012","article-title":"Herpes zoster and severe acute herpetic neuralgia as a complication of COVID-19 infection","volume":"6","author":"Shors","year":"2020","journal-title":"JAAD Case Rep"},{"key":"10.25259\/NMJI_456_21\/ref-4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.25259\/NMJI_456_21\/ref-5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/ijd.15547","article-title":"COVID-19 \u201csecond wave\u201d and vaccines: The dermatologists' perspective","volume":"60","author":"Burlando","year":"2021","journal-title":"Int J Dermatol"},{"key":"10.25259\/NMJI_456_21\/ref-6","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/jocd.14035","article-title":"Herpes zoster following inactivated COVID-19 vaccine: A coexistence or coincidence?","volume":"20","author":"Bostan","year":"2021","journal-title":"J Cosmet Dermatol"}],"container-title":["The National Medical Journal of India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/nmji.in\/herpes-zoster-triggered-by-chadox1-ncov-19-coronavirus-vaccine-recombinant\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nmji.in\/herpes-zoster-triggered-by-chadox1-ncov-19-coronavirus-vaccine-recombinant\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T07:06:39Z","timestamp":1724828799000},"score":1,"resource":{"primary":{"URL":"https:\/\/nmji.in\/herpes-zoster-triggered-by-chadox1-ncov-19-coronavirus-vaccine-recombinant\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":6,"alternative-id":["10.25259\/NMJI_456_21"],"URL":"https:\/\/doi.org\/10.25259\/nmji_456_21","relation":{},"ISSN":["2583-150X","0970-258X"],"issn-type":[{"value":"2583-150X","type":"electronic"},{"value":"0970-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,26]]},"article-number":"89"}}